Works matching AU Habermann, Thomas

Results: 202
    1
    2

    Molecular Features of Diffuse Large B‐Cell Lymphoma Associated With Primary Treatment Resistance.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70006
    By:
    • Bock, Allison M.;
    • Wenzl, Kerstin;
    • Novak, Joseph P.;
    • Stokes, Matthew E.;
    • Hopper, Melissa A.;
    • Krull, Jordan E.;
    • Dropik, Abigail R.;
    • Sarangi, Vivek;
    • Ortiz, Maria;
    • Stong, Nicholas;
    • Huang, C. Chris;
    • Maurer, Matthew J.;
    • King, Rebecca L.;
    • Farooq, Umar;
    • Wang, Yucai;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Cerhan, James R.;
    • Gandhi, Anita K.
    Publication type:
    Article
    3

    Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 4, p. 644, doi. 10.1002/hon.3187
    By:
    • Hopper, Melissa A.;
    • Wenzl, Kerstin;
    • Hartert, Keenan T.;
    • Krull, Jordan E.;
    • Dropik, Abigail R.;
    • Novak, Joseph P.;
    • Manske, Michelle K.;
    • Serres, MaKayla R.;
    • Sarangi, Vivekananda;
    • Larson, Melissa C.;
    • Maurer, Matthew J.;
    • Yang, Zhi‐Zhang;
    • Paludo, Jonas;
    • McPhail, Ellen D.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Rimsza, Lisa M.;
    • Ansell, Stephen M.;
    • Cerhan, James R.;
    • Jevremovic, Dragan
    Publication type:
    Article
    4
    5
    6

    Outcomes in primary cutaneous diffuse large B‐cell lymphoma, leg type.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 5, p. 658, doi. 10.1002/hon.2919
    By:
    • Kraft, Robert M.;
    • Ansell, Stephen M.;
    • Villasboas, Jose C.;
    • Bennani, N. Nora;
    • Wang, Yucai;
    • Habermann, Thomas M.;
    • Thanarajasingam, Gita;
    • Lester, Scott C.;
    • Macon, William;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Micallef, Ivana N.;
    • Witzig, Thomas E.;
    • Thompson, Carrie A.;
    • Johnston, Patrick B.;
    • Nowakowski, Grzegorz S.;
    • Lin, Yi;
    • Paludo, Jonas
    Publication type:
    Article
    7
    8

    FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.

    Published in:
    2017
    By:
    • Ghesquières, Hervé;
    • Larrabee, Beth R.;
    • Haioun, Corinne;
    • Link, Brian K.;
    • Verney, Aurélie;
    • Slager, Susan L.;
    • Ketterer, Nicolas;
    • Ansell, Stephen M.;
    • Delarue, Richard;
    • Maurer, Matthew J.;
    • Fitoussi, Olivier;
    • Habermann, Thomas M.;
    • Peyrade, Fréderic;
    • Dogan, Ahmet;
    • Molina, Thierry J.;
    • Novak, Anne J.;
    • Tilly, Hervé;
    • Cerhan, James R.;
    • Salles, Gilles;
    • Ghesquières, Hervé
    Publication type:
    journal article
    9
    10

    CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.

    Published in:
    Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1475, doi. 10.1007/s00262-013-1452-4
    By:
    • Charbonneau, Bridget;
    • Wang, Alice;
    • Maurer, Matthew;
    • Asmann, Yan;
    • Zent, Clive;
    • Link, Brian;
    • Ansell, Stephen;
    • Weiner, George;
    • Ozsan, Nazan;
    • Feldman, Andrew;
    • Witzig, Thomas;
    • Cunningham, Julie;
    • Dogan, Ahmet;
    • Habermann, Thomas;
    • Slager, Susan;
    • Novak, Anne;
    • Cerhan, James
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    Bleomycin, Lomustine, Cyclophosphamide, Vincristine, Procarbazine and Prednisone (BLEO-CCVPP) in Patients with Hodgkin's Disease who Relapsed after Radiotherapy Alone: a Long-Term Follow-Up Study of the Eastern Cooperative Oncology Group (E3481).

    Published in:
    Leukemia & Lymphoma, 2001, v. 40, n. 3/4, p. 357, doi. 10.3109/10428190109057935
    By:
    • Wiernik, Peter H.;
    • Leong, Traci;
    • Oken, Martin M.;
    • Neiman, Richard S.;
    • Habermann, Thomas M.;
    • Bennett, John M.;
    • Schuster, Stephen;
    • Glick, John H.
    Publication type:
    Article
    17
    18
    19

    Authors' Response.

    Published in:
    2006
    By:
    • Shanafelt, Tait;
    • West, Colin;
    • Kolars, Joseph;
    • Habermann, Thomas
    Publication type:
    Letter
    20
    21
    22
    23
    24

    Smoking, Alcohol Use, Obesity, and Overall Survival From Non-Hodgkin Lymphoma.

    Published in:
    Cancer (0008543X), 2010, v. 116, n. 12, p. 2993, doi. 10.1002/cncr.25114
    By:
    • Geyer, Susan M.;
    • Morton, Lindsay M.;
    • Habermann, Thomas M.;
    • Allmer, Cristine;
    • Davis, Scott;
    • Cozen, Wendy;
    • Severson, Richard K.;
    • Lynch, Charles F.;
    • Wang, Sophia S.;
    • Maurer, Matthew J.;
    • Hartge, Patricia;
    • Cerhan, James R.
    Publication type:
    Article
    25
    26
    27

    Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine–rituximab.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 1, p. 160, doi. 10.1111/bjh.19153
    By:
    • Ramsower, Colleen A.;
    • Rosenthal, Allison;
    • Robetorye, Ryan S.;
    • Mwangi, Raphael;
    • Maurer, Matthew;
    • Villa, Diego;
    • McDonnell, Tim;
    • Feldman, Andrew;
    • Cohen, Jonathon B.;
    • Habermann, Thomas;
    • Campo, Elias;
    • Clot, Guillem;
    • Bühler, Marco M.;
    • Kulis, Marta;
    • Martin‐Subero, Jose Ignacio;
    • Giné, Eva;
    • Cook, James R.;
    • Hill, Brian;
    • Raess, Philipp W.;
    • Beiske, Klaus H.
    Publication type:
    Article
    28

    Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.

    Published in:
    British Journal of Haematology, 2021, v. 195, n. 2, p. 210, doi. 10.1111/bjh.17691
    By:
    • Zanwar, Saurabh;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • Colby, Colin;
    • Larson, Dirk;
    • Paludo, Jonas;
    • He, Rong;
    • Warsame, Rahma;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha Q.;
    • Gonsalves, Wilson;
    • Nowakowski, Grzegorz S.;
    • Dingli, David;
    • Go, Ronald S.;
    • Habermann, Thomas M.;
    • Vincent Rajkumar, S.
    Publication type:
    Article
    29
    30

    Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 4, p. e183, doi. 10.1016/j.clml.2024.11.014
    By:
    • Nastoupil, Loretta J.;
    • Andersen, Clark R.;
    • Ayers, Amy;
    • Yucai Wang;
    • Habermann, Thomas M.;
    • Dai Chihara;
    • Kahl, Brad S.;
    • Link, Brian K.;
    • Koff, Jean L.;
    • Cohen, Jonathon B.;
    • Martin, Peter;
    • Lossos, Izidore S.;
    • Stanchina, Michele;
    • Haddadi, Sara;
    • Casulo, Carla;
    • Ayyappan, Sabarish;
    • Ruitao Lin;
    • Ziyi Li;
    • Larson, Melissa A.;
    • Maurer, Matthew J.
    Publication type:
    Article
    31

    Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. 116, doi. 10.1016/j.clml.2024.07.019
    By:
    • Okcu, Izel;
    • Yucai Wang;
    • Bock, Allison M.;
    • Jihao Zhou;
    • Moustafa, Muhamad Alhaj;
    • Tun, Han W.;
    • Rosenthal, Allison C.;
    • Johnston, Patrick B.;
    • Baidoun, Firas;
    • Khurana, Arushi;
    • Kabat, Brian F.;
    • King, Rebecca L.;
    • Habermann, Thomas M.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    32

    Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e815, doi. 10.1016/j.clml.2022.04.009
    By:
    • Kuhlman, Justin J.;
    • Moustafa, Muhamad Alhaj;
    • Jiang, Liuyan;
    • Iqbal, Madiha;
    • Seegobin, Karan;
    • Wolcott, Zoe;
    • Ayala, Ernesto;
    • Ansell, Steve;
    • Rosenthal, Allison;
    • Paludo, Jonas;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Inwards, David;
    • Habermann, Thomas;
    • Kharfan-Dabaja, Mohamed;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.;
    • Tun, Han W.
    Publication type:
    Article
    33
    34

    IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
    By:
    • Abeykoon, Jithma;
    • Zanwar, Saurabh;
    • Ansell, Stephen;
    • Muchtar, Eli;
    • Rong He;
    • Greipp, Patricia;
    • King, Rebecca;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy;
    • Habermann, Thomas;
    • Inwards, David;
    • Go, Ronald;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie;
    • Witzig, Thomas;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    35
    36

    Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
    By:
    • Abeykoon, Jithma;
    • Zanwar, Saurabh;
    • Ansell, Stephen;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia;
    • King, Rebecca;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy;
    • Habermann, Thomas;
    • Inwards, David;
    • Go, Ronald;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie;
    • Witzig, Thomas;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    37

    Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
    By:
    • Abeykoon, Jithma;
    • Zanwar, Saurabh;
    • Ansell, Stephen;
    • Muchtar, Eli;
    • Rong He;
    • Greipp, Patricia;
    • King, Rebecca;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy;
    • Habermann, Thomas;
    • Inwards, David;
    • Go, Ronald;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie;
    • Witzig, Thomas;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    38

    A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.

    Published in:
    2018
    By:
    • Padrnos, Leslie;
    • Ernst, Brenda;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Toro, Angela;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Nowakowski, Grzegorz S.;
    • Colgan, Joseph;
    • Porrata, Luis;
    • Ansell, Stephen M.;
    • Witzig, Thomas E.;
    • Reeder, Craig
    Publication type:
    journal article
    39
    40
    41
    42

    Author reply.

    Published in:
    2000
    By:
    • Fonseca, Rafael;
    • Inwards, David J.;
    • Habermann, Thomas M.;
    • Egan, Kathleen S.;
    • Fonseca, R;
    • Inwards, DJ;
    • Habermann, TM;
    • Egan, KS
    Publication type:
    journal article
    43

    Testicular lymphoma is associated with a high incidence of extranodal recurrence.

    Published in:
    2000
    By:
    • Fonseca, Rafael;
    • Habermann, Thomas M.;
    • Colgan, Joseph P.;
    • O'Neill, Brian P.;
    • White, William L.;
    • Witzig, Thomas E.;
    • Egan, Kathleen S.;
    • Martenson, James A.;
    • Burgart, Lawrence J.;
    • Inwards, David J.;
    • Fonseca, R;
    • Habermann, T M;
    • Colgan, J P;
    • O'Neill, B P;
    • White, W L;
    • Witzig, T E;
    • Egan, K S;
    • Martenson, J A;
    • Burgart, L J;
    • Inwards, D J
    Publication type:
    journal article
    44

    Risk of Lymphoma in Inflammatory Bowel Disease.

    Published in:
    American Journal of Gastroenterology (Springer Nature), 2000, v. 95, n. 9, p. 2308, doi. 10.1111/j.1572-0241.2000.02316.x
    By:
    • Loftus Jr., Edward V.;
    • Tremaine, William J.;
    • Habermann, Thomas M.;
    • Harmsen, W. Scott;
    • Zinsmeister, Alan R.;
    • Sandbom, William J.
    Publication type:
    Article
    45
    46
    47
    48
    49
    50